Literature DB >> 9468229

Milk thistle (Silybum marianum) for the therapy of liver disease.

K Flora1, M Hahn, H Rosen, K Benner.   

Abstract

Silymarin, derived from the milk thistle plant, Silybum marianum, has been used for centuries as a natural remedy for diseases of the liver and biliary tract. As interest in alternative therapy has emerged in the United States, gastroenterologists have encountered increasing numbers of patients taking silymarin with little understanding of its purported properties. Silymarin and its active constituent, silybin, have been reported to work as antioxidants scavenging free radicals and inhibiting lipid peroxidation. Studies also suggest that they protect against genomic injury, increase hepatocyte protein synthesis, decrease the activity of tumor promoters, stabilize mast cells, chelate iron, and slow calcium metabolism. In this article we review silymarin's history, pharmacology, and properties, and the clinical trials pertaining to patients with acute and chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9468229     DOI: 10.1111/j.1572-0241.1998.00139.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  101 in total

1.  Effects of long-term silymarin oral supplementation on the blood biochemical profile of rainbow trout (Oncorhynchus mykiss).

Authors:  Mahdi Banaee; Antoni Sureda; Ali Reza Mirvaghefi; Golam Reza Rafei
Journal:  Fish Physiol Biochem       Date:  2011-04-26       Impact factor: 2.794

Review 2.  Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Melanie D Beaton
Journal:  Can J Gastroenterol       Date:  2012-06       Impact factor: 3.522

Review 3.  Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences.

Authors:  Enoche F Oga; Shuichi Sekine; Yoshihisa Shitara; Toshiharu Horie
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-04       Impact factor: 2.441

4.  In vitro determination of anticryptosporidial activity of phytogenic extracts and compounds.

Authors:  Klaus Teichmann; Maxime Kuliberda; Gerd Schatzmayr; Franz Hadacek; Anja Joachim
Journal:  Parasitol Res       Date:  2012-01-26       Impact factor: 2.289

5.  Effect of silymarin in the prevention of Cisplatin nephrotoxicity, a clinical trial study.

Authors:  Ali Momeni; Ali Hajigholami; Shohreh Geshnizjani; Soleiman Kheiri
Journal:  J Clin Diagn Res       Date:  2015-04-01

Review 6.  Propylthiouracil for alcoholic liver disease.

Authors:  Giuseppe Fede; Giacomo Germani; Christian Gluud; Kurinchi Selvan Gurusamy; Andrew K Burroughs
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

7.  Estrogen Receptors Are Involved in the Neuroprotective Effect of Silibinin in Aβ1-42-Treated Rats.

Authors:  Xiaoyu Song; Bo Liu; Lingyu Cui; Biao Zhou; Lu Liu; Weiwei Liu; Guodong Yao; Mingyu Xia; Toshihiko Hayashi; Shunji Hattori; Yuko Ushiki-Kaku; Shin-Ichi Tashiro; Takashi Ikejima
Journal:  Neurochem Res       Date:  2018-02-03       Impact factor: 3.996

8.  A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients.

Authors:  Thomas W Flaig; Daniel L Gustafson; Lih-Jen Su; Joseph A Zirrolli; Frances Crighton; Gail S Harrison; A Scott Pierson; Rajesh Agarwal; L Michael Glodé
Journal:  Invest New Drugs       Date:  2006-11-01       Impact factor: 3.850

Review 9.  Meta-analysis: silymarin and its combination therapy for the treatment of chronic hepatitis B.

Authors:  F Wei; S-K Liu; X-Y Liu; Z-J Li; B Li; Y-L Zhou; H-Y Zhang; Y-W Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-18       Impact factor: 3.267

10.  Silymarin secretion and its elicitation by methyl jasmonate in cell cultures of Silybum marianum is mediated by phospholipase D-phosphatidic acid.

Authors:  Elena Madrid; Purificación Corchete
Journal:  J Exp Bot       Date:  2009-12-09       Impact factor: 6.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.